Myelopathy Associated with Rapid Progression of a Dystrophic Neurofibromatosis-1 Curve - A Case Report and Review of Literature

与快速进展型营养不良性神经纤维瘤病-1曲线相关的脊髓病——病例报告及文献综述

阅读:1

Abstract

INTRODUCTION: Thoracic myelopathy in neuro fibromatosis-1 (NF-1) is most commonly due to intra-spinal neurofibromas/dumb-bell tumors/intra-canal rib head penetration (RHP) causing cord compression. However, acute thoracic myelopathy due to rapid progression of the kyphoscoliotic curve alone in NF-1 without a significant spinal cord compression occurs very rarely. This case report discusses our experience with one such patient and we also discuss intraoperative and post-operative challenges encountered with this patient and a rare complication of hemothorax postoperatively. CASE REPORT: A 15-year-old male presented to the clinic after being lost to follow-up for 4 years with a rapid acute deterioration of dystrophic curve and no myelopathic symptoms (Scoliosis - 65°, Kyphosis - 77°). His subsequent examination in 6 weeks showed acute development of myelopathic gait with right ankle and extensor hallucis longus weakness. He was admitted for halo gravity traction for 6 weeks and a single-stage posterior instrumentation with excision of rib heads at the apex was planned. Postoperatively, the patient developed massive left hemothorax and loss of power in both lower limbs at day 2. He subsequently regained full power and complete resolution of myelopathic symptoms at the end of 9- month follow-up with a satisfactory alignment of spine in the follow-up X-rays. CONCLUSION: Acute onset of myelopathy is a rare and uncommon finding with a rapid deterioration of dystrophic curve alone without any major spinal cord compromise. Early detection of dysplastic changes with early aggressive surgical management and deformity correction is necessary with dystrophic NF-1 curves to prevent pre-operative and post-operative morbidities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。